(MRAM) Everspin Technologies - Overview
Sector: Technology | Industry: Semiconductors | Exchange: NASDAQ (USA) | Market Cap: 220m USD | Total Return: 103.7% in 12m
Industry Rotation: +7.6
Avg Turnover: 2.36M USD
Peers RS (IBD): 40.2
EPS Trend: -37.9%
Qual. Beats: 0
Rev. Trend: -40.6%
Qual. Beats: 1
Warnings
Altman Z'' -10.89 < 1.0 - financial distress zone
Volatile
Tailwinds
No distinct edge detected
Everspin Technologies, Inc. (MRAM) designs, manufactures, and sells magnetoresistive random access memory (MRAM) products globally. MRAM is a non-volatile RAM technology with potential for high speed and data retention, positioning it as a key component in advanced electronics. The company offers Toggle MRAM, spin-transfer torque MRAM, and tunnel magnetoresistance sensor products, along with MRAM foundry services.
MRAMs target markets include industrial, medical, automotive/transportation, aerospace, and data center applications. These sectors increasingly demand reliable, high-performance memory solutions. Everspin sells directly to original equipment manufacturers (OEMs), contract manufacturers, and original design manufacturers (ODMs), supplemented by a network of representatives and distributors. For more detailed financial analysis, consider exploring ValueRay.
- MRAM adoption in data centers drives revenue growth
- Automotive and industrial markets increase MRAM demand
- Competition from alternative memory technologies impacts market share
- Manufacturing costs of MRAM influence profit margins
| Net Income: -526k TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.10 > 1.0 |
| NWC/Revenue: 93.67% < 20% (prev 107.7%; Δ -14.04% < -1%) |
| CFO/TA 0.12 > 3% & CFO 9.96m > Net Income -526k |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (23.8m) vs 12m ago 8.10% < -2% |
| Gross Margin: 51.16% > 18% (prev 0.52%; Δ 5.06k% > 0.5%) |
| Asset Turnover: 67.98% > 50% (prev 64.79%; Δ 3.19% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
| A: 0.61 (Total Current Assets 65.2m - Total Current Liabilities 13.5m) / Total Assets 84.6m |
| B: -1.62 (Retained Earnings -137.5m / Total Assets 84.6m) |
| C: -0.06 (EBIT TTM -4.91m / Avg Total Assets 81.2m) |
| D: -8.76 (Book Value of Equity -137.5m / Total Liabilities 15.7m) |
| Altman-Z'' Score: -10.89 = D |
| DSRI: 0.63 (Receivables 8.10m/11.7m, Revenue 55.2m/50.4m) |
| GMI: 1.01 (GM 51.16% / 51.84%) |
| AQI: 0.32 (AQ_t 0.02 / AQ_t-1 0.07) |
| SGI: 1.10 (Revenue 55.2m / 50.4m) |
| TATA: -0.12 (NI -526k - CFO 9.96m) / TA 84.6m) |
| Beneish M-Score: -3.78 (Cap -4..+1) = AAA |
Over the past week, the price has changed by +5.92%, over one month by +1.86%, over three months by -22.29% and over the past year by +103.72%.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 12.5 | 34.3% |
P/S = 3.9789
P/B = 3.1787
P/EG = -0.6
Revenue TTM = 55.2m USD
EBIT TTM = -4.91m USD
EBITDA TTM = -1.70m USD
Long Term Debt = 3.34m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 4.62m USD (from shortTermDebt, last quarter)
Debt = 6.59m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -37.9m USD (from netDebt column, last quarter)
Enterprise Value = 181.8m USD (219.6m + Debt 6.59m - CCE 44.5m)
Interest Coverage Ratio = unknown (Ebit TTM -4.91m / Interest Expense TTM 0.0)
EV/FCF = 58.23x (Enterprise Value 181.8m / FCF TTM 3.12m)
FCF Yield = 1.72% (FCF TTM 3.12m / Enterprise Value 181.8m)
FCF Margin = 5.66% (FCF TTM 3.12m / Revenue TTM 55.2m)
Net Margin = -0.95% (Net Income TTM -526k / Revenue TTM 55.2m)
Gross Margin = 51.16% ((Revenue TTM 55.2m - Cost of Revenue TTM 27.0m) / Revenue TTM)
Gross Margin QoQ = 50.77% (prev 51.25%)
Tobins Q-Ratio = 2.15 (Enterprise Value 181.8m / Total Assets 84.6m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 6.59m)
Taxrate = 9.67% (128k / 1.32m)
NOPAT = -4.44m (EBIT -4.91m * (1 - 9.67%)) [loss with tax shield]
Current Ratio = 4.84 (Total Current Assets 65.2m / Total Current Liabilities 13.5m)
Debt / Equity = 0.10 (Debt 6.59m / totalStockholderEquity, last quarter 68.9m)
Debt / EBITDA = 22.27 (negative EBITDA) (Net Debt -37.9m / EBITDA -1.70m)
Debt / FCF = -12.13 (Net Debt -37.9m / FCF TTM 3.12m)
Total Stockholder Equity = 65.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.65% (Net Income -526k / Total Assets 84.6m)
RoE = -0.80% (Net Income TTM -526k / Total Stockholder Equity 65.5m)
RoCE = -7.14% (EBIT -4.91m / Capital Employed (Equity 65.5m + L.T.Debt 3.34m))
RoIC = -6.78% (negative operating profit) (NOPAT -4.44m / Invested Capital 65.5m)
WACC = 10.80% (E(219.6m)/V(226.2m) * Re(11.12%) + D(6.59m)/V(226.2m) * Rd(0.0%) * (1-Tc(0.10)))
Discount Rate = 11.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.98%
[DCF] Terminal Value 70.89% ; FCFF base≈2.68m ; Y1≈2.99m ; Y5≈3.97m
[DCF] Fair Price = 3.55 (EV 44.3m - Net Debt -37.9m = Equity 82.1m / Shares 23.1m; r=10.80% [WACC]; 5y FCF grow 13.58% → 3.0% )
EPS Correlation: -37.86 | EPS CAGR: -33.39% | SUE: -0.07 | # QB: 0
Revenue Correlation: -40.62 | Revenue CAGR: 0.84% | SUE: 0.91 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.07 | Chg7d=-0.005 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=0.27 | Chg7d=-0.030 | Chg30d=-0.030 | Revisions Net=+0 | Growth EPS=+22.7% | Growth Revenue=+7.9%
EPS next Year (2027-12-31): EPS=0.25 | Chg7d=+0.010 | Chg30d=+0.010 | Revisions Net=-1 | Growth EPS=-7.4% | Growth Revenue=+7.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)